Eli Lilly and Company (LLY)
NYSE · Healthcare · Drug Manufacturers - General
Eli Lilly and Company is a Healthcare company with a market capitalization of $1.08T, a trailing P/E ratio of 42.9, and a dividend yield of 0.55%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $8.55 | $6.79 | +25.9% |
| Q4 2025 | February 4, 2026 | $7.54 | $7.17 | +5.2% |
| Q3 2025 | October 30, 2025 | $7.02 | $5.89 | +19.2% |
| Q2 2025 | August 7, 2025 | $6.29 | $5.50 | +14.4% |
| Q1 2025 | May 1, 2025 | $3.06 | $4.11 | -25.6% |
| Q4 2024 | February 6, 2025 | $5.32 | $5.07 | +5.0% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Eli Lilly and Company's market cap?
As of June 29, 2026, Eli Lilly and Company (LLY) has a market capitalization of $1.08T.
What is Eli Lilly and Company's P/E ratio?
Eli Lilly and Company trades at a trailing price-to-earnings (P/E) ratio of 42.9. Its forward P/E is 31.1.
Does Eli Lilly and Company pay a dividend?
Yes — Eli Lilly and Company pays a dividend yielding 0.55%, an annual payout of $6.23 per share.
What sector is LLY in?
Eli Lilly and Company is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was Eli Lilly and Company's revenue?
In its latest reported fiscal year (ending December 31, 2025), Eli Lilly and Company reported revenue of $65.18B and net income of $20.64B.
Ask your own questions about LLY
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.